Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aging in magma rheology.
Kurokawa AK, Miwa T, Ishibashi H. Kurokawa AK, et al. Among authors: miwa t. Sci Rep. 2022 Jun 15;12(1):10015. doi: 10.1038/s41598-022-14327-2. Sci Rep. 2022. PMID: 35705673 Free PMC article.
Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury.
Nagashima K, Miwa T, Soumiya H, Ushiro D, Takeda-Kawaguchi T, Tamaoki N, Ishiguro S, Sato Y, Miyamoto K, Ohno T, Osawa M, Kunisada T, Shibata T, Tezuka KI, Furukawa S, Fukumitsu H. Nagashima K, et al. Among authors: miwa t. Sci Rep. 2017 Oct 18;7(1):13500. doi: 10.1038/s41598-017-13373-5. Sci Rep. 2017. PMID: 29044129 Free PMC article.
Thoracoscopic enucleation of an esophageal glomus tumor in the prone position: a case report and literature review.
Matsumoto S, Okumura T, Miwa T, Numata Y, Hamashima T, Ito M, Nagaoka Y, Takeshita C, Sakai A, Kimura N, Fukasawa M, Mori K, Takeda N, Yagi K, Muranushi R, Manabe T, Shirai Y, Watanabe T, Hirano K, Hashimoto I, Shibuya K, Yoshioka I, Fujii T. Matsumoto S, et al. Among authors: miwa t. Surg Case Rep. 2024 May 28;10(1):131. doi: 10.1186/s40792-024-01934-6. Surg Case Rep. 2024. PMID: 38805072 Free PMC article.
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
Inomata M, Minatoyama S, Takata N, Hayashi K, Hirai T, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: miwa t. Mol Clin Oncol. 2024 May 1;20(6):43. doi: 10.3892/mco.2024.2741. eCollection 2024 Jun. Mol Clin Oncol. 2024. PMID: 38756869 Free PMC article.
1,142 results